UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 239

Sortiert nach

Mendelian Randomization Study Using Dopaminergic Neuron‐Specific eQTL Nominates Potential Causal Genes for Parkinson's Disease

Movement disorders, 2022-12, Vol.37 (12), p.2451-2456

2022

Volltextzugriff (PDF)

Functional genomics reveal gene regulatory mechanisms underlying schizophrenia risk

Nature communications, 2019-02, Vol.10 (1), p.670-19, Article 670

2019

Volltextzugriff (PDF)

In vivo study sheds new light on the dendritic spine pathology hypothesis of schizophrenia

Molecular psychiatry, 2022-04, Vol.27 (4), p.1866-1868

2022

Volltextzugriff (PDF)

SZDB: A Database for Schizophrenia Genetic Research

Schizophrenia bulletin, 2017-03, Vol.43 (2), p.459-471

2017

Volltextzugriff (PDF)

SZDB2.0: an updated comprehensive resource for schizophrenia research

Human genetics, 2020-10, Vol.139 (10), p.1285-1297

2020

Volltextzugriff (PDF)

Functional variants fine‐mapping and gene function characterization provide insights into the role of ZNF323 in schizophrenia pathogenesis

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2021-01, Vol.186 (1), p.28-39

2021

Volltextzugriff (PDF)

Regulatory mechanisms of major depressive disorder risk variants

Molecular psychiatry, 2020-09, Vol.25 (9), p.1926-1945

2020

Volltextzugriff (PDF)

The schizophrenia susceptibility gene NAGA regulates dendritic spine density: further evidence for the dendritic spine pathology of schizophrenia

Molecular psychiatry, 2021-12, Vol.26 (12), p.7102-7104

2021

Volltextzugriff (PDF)

Integration of GWAS and brain eQTL identifies FLOT1 as a risk gene for major depressive disorder

Neuropsychopharmacology (New York, N.Y.), 2019-08, Vol.44 (9), p.1542-1551

2019

Volltextzugriff (PDF)

The integrated landscape of causal genes and pathways in schizophrenia

Translational psychiatry, 2018-03, Vol.8 (1), p.67-14, Article 67

2018

Volltextzugriff (PDF)

Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes

Nature communications, 2018-02, Vol.9 (1), p.838-16, Article 838

2018

Volltextzugriff (PDF)

A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression

Molecular psychiatry, 2021-11, Vol.26 (11), p.6896-6911

2021

Volltextzugriff (PDF)

Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder

Neuropsychopharmacology (New York, N.Y.), 2018-09, Vol.43 (10), p.2146-2153

2018

Volltextzugriff (PDF)

Proteome-wide Association Study Provides Insights Into the Genetic Component of Protein Abundance in Psychiatric Disorders

Biological psychiatry (1969), 2021-12, Vol.90 (11), p.781-789

2021

Volltextzugriff (PDF)

Transcriptome-wide association study identifies new susceptibility genes and pathways for depression

Translational psychiatry, 2021-05, Vol.11 (1), p.306-13, Article 306

2021

Volltextzugriff (PDF)

Genome wide association study identifies four loci for early onset schizophrenia

Translational psychiatry, 2021-04, Vol.11 (1), p.248-248, Article 248

2021

Volltextzugriff (PDF)

Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder

Neuropsychopharmacology (New York, N.Y.), 2019-08, Vol.44 (9), p.1552-1561

2019

Volltextzugriff (PDF)

Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia

BMC medicine, 2021-08, Vol.19 (1), p.1-15, Article 177

2021

Volltextzugriff (PDF)

Transcriptome-Wide Association Study Provides Insights Into the Genetic Component of Gene Expression in Anxiety

Frontiers in genetics, 2021-09, Vol.12, p.740134-740134

2021

Volltextzugriff (PDF)

Functional genomic analysis delineates regulatory mechanisms of GWAS-identified bipolar disorder risk variants

Genome medicine, 2022-05, Vol.14 (1), p.53-53, Article 53

2022

Volltextzugriff (PDF)

GATA3 controls the specification of prosensory domain and neuronal survival in the mouse cochlea

Human molecular genetics, 2013-09, Vol.22 (18), p.3609-3623

2013

Volltextzugriff (PDF)

Functional genomics elucidates regulatory mechanisms of Parkinson's disease-associated variants

BMC medicine, 2022-02, Vol.20 (1), p.68-68, Article 68

2022

Volltextzugriff (PDF)

Down-Regulation of SIRT1 Gene Expression in Major Depressive Disorder

The American journal of psychiatry, 2016-10, Vol.173 (10), p.1046-1046

2016

Volltextzugriff (PDF)

Mendelian randomization reveals the causal links between microRNA and schizophrenia

Journal of psychiatric research, 2023-07, Vol.163, p.372-377

2023

Volltextzugriff (PDF)

Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders

Neuropsychopharmacology (New York, N.Y.), 2023-01, Vol.48 (2), p.270-280

2023

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Englisch
(218)
Japanisch
(27)
Chinesisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(179)
Life Sciences & Biomedicine
(118)
Humans
(91)
Schizophrenia
(50)
Psychiatry
(49)
Male
(46)
Animals
(36)
Female
(35)
Technology
(35)
Schizophrenia - Genetics
(30)
Genome-Wide Association Study
(29)
Genomes
(27)
Neurosciences & Neurology
(27)
Neurosciences
(26)
Physical Sciences
(25)
Adult
(24)
Genetic Predisposition To Disease
(23)
Polymorphism, Single Nucleotide - Genetics
(23)
Engineering
(21)
Gene Expression
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Mendelian Randomization Study Using Dopaminergic Neuron‐Specific eQTL Nominates Potential Causal Genes for Parkinson's Disease

Functional genomics reveal gene regulatory mechanisms underlying schizophrenia risk

In vivo study sheds new light on the dendritic spine pathology hypothesis of schizophrenia

SZDB: A Database for Schizophrenia Genetic Research

SZDB2.0: an updated comprehensive resource for schizophrenia research

Functional variants fine‐mapping and gene function characterization provide insights into the role of ZNF323 in schizophrenia pathogenesis

Regulatory mechanisms of major depressive disorder risk variants

The schizophrenia susceptibility gene NAGA regulates dendritic spine density: further evidence for the dendritic spine pathology of schizophrenia

Integration of GWAS and brain eQTL identifies FLOT1 as a risk gene for major depressive disorder

The integrated landscape of causal genes and pathways in schizophrenia

Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes

A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression

Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder

Proteome-wide Association Study Provides Insights Into the Genetic Component of Protein Abundance in Psychiatric Disorders

Transcriptome-wide association study identifies new susceptibility genes and pathways for depression

Genome wide association study identifies four loci for early onset schizophrenia

Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder

Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia

Transcriptome-Wide Association Study Provides Insights Into the Genetic Component of Gene Expression in Anxiety

Functional genomic analysis delineates regulatory mechanisms of GWAS-identified bipolar disorder risk variants

GATA3 controls the specification of prosensory domain and neuronal survival in the mouse cochlea

Functional genomics elucidates regulatory mechanisms of Parkinson's disease-associated variants

Down-Regulation of SIRT1 Gene Expression in Major Depressive Disorder

Mendelian randomization reveals the causal links between microRNA and schizophrenia

Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders

Suchergebnisse filtern